Atlantic Trust Group LLC increased its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 300.1% in the third quarter, Holdings Channel reports. The institutional investor owned 1,046,190 shares of the pharmacy operator’s stock after acquiring an additional 784,677 shares during the quarter. Atlantic Trust Group LLC’s holdings in Walgreens Boots Alliance were worth $80,787,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of WBA. Koshinski Asset Management Inc. increased its stake in shares of Walgreens Boots Alliance by 16.6% in the second quarter. Koshinski Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $832,000 after buying an additional 1,515 shares during the last quarter. Atria Investments LLC boosted its holdings in Walgreens Boots Alliance by 23.7% in the second quarter. Atria Investments LLC now owns 24,079 shares of the pharmacy operator’s stock worth $1,886,000 after purchasing an additional 4,614 shares during the period. RB Capital Management LLC boosted its holdings in Walgreens Boots Alliance by 4.3% in the second quarter. RB Capital Management LLC now owns 4,138 shares of the pharmacy operator’s stock worth $324,000 after purchasing an additional 169 shares during the period. Heritage Investors Management Corp acquired a new position in Walgreens Boots Alliance in the second quarter worth $262,000. Finally, Capital Investment Advisors LLC boosted its holdings in Walgreens Boots Alliance by 7.6% in the second quarter. Capital Investment Advisors LLC now owns 6,027 shares of the pharmacy operator’s stock worth $472,000 after purchasing an additional 428 shares during the period. Institutional investors and hedge funds own 61.20% of the company’s stock.

In other news, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $76.07 on Tuesday. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00. The stock has a market cap of $75,340.00, a price-to-earnings ratio of 21.01, a PEG ratio of 1.29 and a beta of 1.22. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same quarter in the previous year, the company posted $1.10 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.7 EPS for the current year.

Walgreens Boots Alliance announced that its Board of Directors has authorized a share repurchase plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

A number of research firms have commented on WBA. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a report on Saturday. Pivotal Research set a $73.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday, January 5th. Finally, Royal Bank of Canada began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Nine analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus target price of $86.20.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance Inc (WBA) Shares Bought by Atlantic Trust Group LLC” was first published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-bought-by-atlantic-trust-group-llc/1808755.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.